Short Interest in Certara, Inc. (NASDAQ:CERT) Grows By 7.4%

Certara, Inc. (NASDAQ:CERT) saw a large growth in short interest in March. As of March 31st, there was short interest totalling 5,670,000 shares, a growth of 7.4% from the March 15th total of 5,280,000 shares. Approximately 5.2% of the shares of the stock are sold short. Based on an average daily volume of 550,800 shares, the short-interest ratio is currently 10.3 days.

Certara Trading Down 2.1 %

Shares of CERT stock opened at $17.07 on Wednesday. The firm has a 50-day moving average price of $17.86 and a 200 day moving average price of $16.15. Certara has a twelve month low of $11.81 and a twelve month high of $24.96. The company has a market capitalization of $2.73 billion, a price-to-earnings ratio of -48.77, a PEG ratio of 1.82 and a beta of 1.63. The company has a current ratio of 2.62, a quick ratio of 2.62 and a debt-to-equity ratio of 0.28.

Certara (NASDAQ:CERT) last posted its quarterly earnings results on Thursday, February 29th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.04). The business had revenue of $88.01 million during the quarter, compared to analysts’ expectations of $86.80 million. Certara had a negative net margin of 15.62% and a positive return on equity of 4.33%. Research analysts forecast that Certara will post 0.29 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on CERT shares. SVB Leerink started coverage on Certara in a research note on Monday, February 26th. They set a “market perform” rating and a $19.00 price target for the company. JMP Securities started coverage on Certara in a research note on Thursday, April 4th. They set a “market perform” rating for the company. UBS Group lifted their price target on Certara from $17.00 to $20.00 and gave the stock a “neutral” rating in a research note on Friday, March 1st. Barclays lifted their price target on Certara from $16.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 25th. Finally, Jefferies Financial Group boosted their target price on shares of Certara from $14.00 to $15.50 and gave the company a “hold” rating in a research note on Friday, March 1st. Seven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, Certara has a consensus rating of “Hold” and a consensus price target of $20.06.

Insiders Place Their Bets

In other Certara news, SVP Richard M. Traynor sold 6,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $18.00, for a total transaction of $108,000.00. Following the sale, the senior vice president now directly owns 165,368 shares in the company, valued at approximately $2,976,624. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Certara news, SVP Richard M. Traynor sold 6,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $18.00, for a total transaction of $108,000.00. Following the sale, the senior vice president now directly owns 165,368 shares in the company, valued at approximately $2,976,624. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Richard M. Traynor sold 3,000 shares of Certara stock in a transaction on Monday, April 1st. The stock was sold at an average price of $18.00, for a total value of $54,000.00. Following the transaction, the senior vice president now directly owns 173,524 shares of the company’s stock, valued at approximately $3,123,432. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 23,427 shares of company stock worth $405,095. Corporate insiders own 2.60% of the company’s stock.

Institutional Trading of Certara

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CERT. Tower Research Capital LLC TRC grew its holdings in Certara by 584.8% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,356 shares of the company’s stock valued at $25,000 after buying an additional 1,158 shares during the period. Pineridge Advisors LLC purchased a new stake in Certara in the 4th quarter valued at about $28,000. State of Wyoming grew its holdings in Certara by 103.1% in the 2nd quarter. State of Wyoming now owns 2,027 shares of the company’s stock valued at $37,000 after buying an additional 1,029 shares during the period. Covestor Ltd grew its holdings in Certara by 14,940.0% in the 3rd quarter. Covestor Ltd now owns 3,760 shares of the company’s stock valued at $55,000 after buying an additional 3,735 shares during the period. Finally, Advisors Asset Management Inc. grew its holdings in shares of Certara by 42.9% during the 3rd quarter. Advisors Asset Management Inc. now owns 4,710 shares of the company’s stock worth $68,000 after purchasing an additional 1,414 shares during the period. Hedge funds and other institutional investors own 73.96% of the company’s stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.